KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company which focuses on the discovery and development of proprietary new molecular entity prodrugs. Its product pipeline includes KP415, methylphenidate drug for ADHD; KP511/ER, KP201/IR, KP606/IR and KP746 drugs for the treatment of pain. It is also developing KP303, which is a quetiapine antipsychotic drug to treat multiple central nervous system disorders. KemPharm uses ligand activated therapy (LAT), which is a platform technology to produce new molecular entity prodrugs. The company focuses on therapeutic areas such as pain, Attention deficit hyperactivity disorder (ADHD) and other central nervous system indications. KemPharm is headquartered in Coralville, Iowa, the US.
KemPharm Inc Key Recent Developments
Nov 09, 2017: KemPharm Reports Third Quarter 2017 Results and Provides Corporate Update
Aug 10, 2017: KemPharm Reports Second Quarter 2017 Results
Jun 01, 2017: KemPharm Announces Addition to Leadership Team
May 10, 2017: KemPharm Reports First Quarter 2017 Results
Mar 09, 2017: KemPharm Reports Fourth Quarter and Year End 2016 Results
This comprehensive SWOT profile of KemPharm Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of KemPharm Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- KemPharm Inc - Key Information
- KemPharm Inc - Overview
- KemPharm Inc - Key Employees
- KemPharm Inc - Key Employee Biographies
- KemPharm Inc - Key Operational Heads
- KemPharm Inc - Major Products and Services
- KemPharm Inc - History
- KemPharm Inc - Company Statement
- KemPharm Inc - Locations And Subsidiaries
- KemPharm Inc - Key Manufacturing facilities
- Head Office
- Other Locations & Subsidiaries
- KemPharm Inc - Business Description
- KemPharm Inc - Corporate Strategy
- KemPharm Inc - SWOT Analysis
- SWOT Analysis - Overview
- KemPharm Inc - Strengths
- KemPharm Inc - Weaknesses
- KemPharm Inc - Opportunities
- KemPharm Inc - Threats
- KemPharm Inc - Key Competitors
- KemPharm Inc - Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Ratio Definitions
List of Tables
- KemPharm Inc, Key Information
- KemPharm Inc, Key Ratios
- KemPharm Inc, Share Data
- KemPharm Inc, Major Products and Services
- KemPharm Inc, History
- KemPharm Inc, Key Employees
- KemPharm Inc, Key Employee Biographies
- KemPharm Inc, Key Operational Heads
- KemPharm Inc, Other Locations
- KemPharm Inc, Subsidiaries
- KemPharm Inc, Key Manufacturing facilities
- KemPharm Inc, Key Competitors
- KemPharm Inc, SWOT Analysis
- KemPharm Inc, Ratios based on current share price
- KemPharm Inc, Annual Ratios
- KemPharm Inc, Interim Ratios
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- KemPharm Inc, Performance Chart
- KemPharm Inc, Ratio Charts